Neurentmedical
87 employees on LinkedIn · 2 known investors
Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device used in ENT surgery to disrupt overactive posterior nasal nerves and treat chronic rhinitis. The device is intended for physicians treating patients with chronic rhinitis symptoms such as congestion, runny nose, and post-nasal drip.
Investors · 2
Frequently asked questions
- What does Neurentmedical do?
- Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device used in ENT surgery to disrupt overactive posterior nasal nerves and treat chronic rhinitis. The device is intended for physicians treating patients with chronic rhinitis symptoms such as congestion, runny nose, and post-nasal drip.
- Who are Neurentmedical's investors?
- Neurentmedical's investors include Fountain Healthcare Partners, Atlantic Bridge Ventures.